Income Statement Henry Schein, Inc.

Stocks

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 15/06/2026 BST			5-day change	1st Jan Change
81.09 ^USD	-0.20%		+3.89%	+7.29%

06-11	Henry Schein Shares Rise After BTIG Upgrade	MT
06-11	BTIG Upgrades Henry Schein to Buy From Neutral, Price Target is $100	MT

a9f0f873d1a10251fe21ec0ae5.WeOs7SKlWlX-slq0854jaPwusL5wVZKLILvDjeoNyEU.M6HU3VrXORuU1R_6oq1IHp1Y4clAZ_Pdc8yc-aNngwc6sfyYTcc4eLTwKQ

Published financial data: HENRY SCHEIN, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	12.4B	12.65B	12.34B	12.67B	13.18B
Total Revenues	12.4B	12.65B	12.34B	12.67B	13.18B
Cost of Goods Sold, Total	8.73B	8.82B	8.48B	8.66B	9.08B
Gross Profit	3.67B	3.83B	3.86B	4.02B	4.1B
Selling General & Admin Expenses, Total	2.82B	2.77B	2.96B	3.01B	3.1B
Depreciation & Amortization - (IS)	-	182M	210M	251M	263M
Other Operating Expenses, Total	2.82B	2.95B	3.17B	3.26B	3.36B
Operating Income	848M	878M	695M	751M	742M
Interest Expense, Total	-27.6M	-44M	-87M	-131M	-150M
Interest And Investment Income	6.45M	17M	17M	24M	33M
Net Interest Expenses	-21.15M	-27M	-70M	-107M	-117M
Income (Loss) On Equity Invest.	20.01M	15M	14M	13M	12M
Other Non Operating Income (Expenses)	12.14M	1M	-3M	-1M	-3M
EBT, Excl. Unusual Items	859M	867M	636M	656M	634M
Restructuring Charges	-7.94M	-131M	-80M	-110M	-105M
Merger & Related Restructuring Charges	-	-	-	-6M	-6M
Gain (Loss) On Sale Of Investments	7.32M	-	-	-	-
Asset Writedown	-713K	-	-	-	-
Insurance Settlements	-	-	-	40M	20M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-54M	2M
EBT, Incl. Unusual Items	858M	736M	556M	526M	545M
Income Tax Expense	197M	170M	120M	128M	126M
Earnings From Continuing Operations	661M	566M	436M	398M	419M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	661M	566M	436M	398M	419M
Minority Interest	-29.29M	-28M	-20M	-8M	-21M
Net Income - (IS)	631M	538M	416M	390M	398M
Net Income to Common Incl Extra Items	631M	538M	416M	390M	398M
Net Income to Common Excl. Extra Items	631M	538M	416M	390M	398M
Per Share Items
Net EPS - Basic	4.51	3.95	3.18	3.08	3.29
Basic EPS - Continuing Operations	4.51	3.95	3.18	3.08	3.29
Basic Weighted Average Shares Outstanding	140M	136M	131M	127M	121M
Net EPS - Diluted	4.45	3.91	3.16	3.05	3.27
Diluted EPS - Continuing Operations	4.45	3.91	3.16	3.05	3.27
Diluted Weighted Average Shares Outstanding	142M	138M	132M	128M	122M
Normalized Basic EPS	3.62	3.78	2.89	3.17	3.11
Normalized Diluted EPS	3.58	3.73	2.87	3.15	3.08
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.06B	1.09B	943M	1.02B	1.02B
EBITA	972M	1B	847M	936M	922M
EBIT	848M	878M	695M	751M	742M
EBITDAR	1.16B	1.24B	1.06B	1.15B	1.14B
Effective Tax Rate - (Ratio)	23	23.1	21.58	24.33	23.12
Current Domestic Taxes	166M	199M	100M	133M	57M
Current Foreign Taxes	42.75M	44M	40M	56M	64M
Total Current Taxes	208M	243M	140M	189M	121M
Deferred Domestic Taxes	-14.68M	-61M	6M	-41M	36M
Deferred Foreign Taxes	3.7M	-12M	-26M	-20M	-31M
Total Deferred Taxes	-10.98M	-73M	-20M	-61M	5M
Normalized Net Income	508M	514M	378M	402M	375M
Interest on Long-Term Debt	114K	-	-	-	-
Non-Cash Pension Expense	708K	1M	-1M	-1M	-2M
Supplemental Operating Expense Items
Advertising Expense	45.9M	47M	47M	43M	46M
Selling and Marketing Expenses	96.7M	-	-	-	-
Net Rental Expense, Total	103M	150M	121M	130M	115M
Imputed Operating Lease Interest Expense	20.59M	38.91M	39.74M	48.45M	43.73M
Imputed Operating Lease Depreciation	82.87M	111M	81.26M	81.55M	71.27M
Stock-Based Comp., SG&A Exp. (Total)	78.42M	54M	39M	39M	39M
Total Stock-Based Compensation	78.42M	54M	39M	39M	39M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	118M	117M	171M	122M	156M
Total Cash And Short Term Investments	118M	117M	171M	122M	156M
Accounts Receivable, Total	1.45B	1.44B	1.86B	1.48B	1.65B
Total Receivables	1.45B	1.44B	1.86B	1.48B	1.65B
Inventory	1.86B	1.96B	1.82B	1.81B	2B
Prepaid Expenses	413M	466M	639M	569M	655M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	3.84B	3.99B	4.49B	3.98B	4.46B
Gross Property Plant And Equipment	1.24B	1.24B	1.5B	1.49B	1.68B
Accumulated Depreciation	-550M	-573M	-672M	-670M	-759M
Net Property Plant And Equipment	691M	667M	823M	824M	922M
Long-term Investments	168M	161M	180M	170M	174M
Goodwill	2.85B	2.89B	3.88B	3.89B	4.21B
Other Intangibles, Total	733M	666M	1.01B	1.11B	1.13B
Loans Receivable Long-Term	35.75M	28M	44M	63M	56M
Deferred Tax Assets Long-Term	34.61M	88M	38M	47M	92M
Other Long-Term Assets, Total	120M	116M	114M	131M	164M
Total Assets	8.48B	8.61B	10.57B	10.22B	11.22B
Liabilities
Accounts Payable, Total	1.05B	1B	1.02B	962M	1.15B
Accrued Expenses, Total	885M	796M	920M	794M	868M
Short-term Borrowings	50.53M	103M	264M	650M	764M
Current Portion of Long-Term Debt	7.42M	2M	146M	56M	33M
Current Portion of Leases	79.61M	77M	84M	78M	81M
Current Income Taxes Payable	137M	132M	137M	139M	179M
Unearned Revenue Current, Total	89.2M	86M	89M	81M	81M
Other Current Liabilities	4.32M	24M	23M	43M	68M
Total Current Liabilities	2.31B	2.22B	2.68B	2.8B	3.23B
Long-Term Debt	807M	1.03B	1.93B	1.83B	2.31B
Long-Term Leases	272M	281M	314M	262M	255M
Unearned Revenue Non Current	9.7M	8M	9M	8M	9M
Pension & Other Post Retirement Benefits	52.15M	59M	65M	68M	76M
Deferred Tax Liability Non Current	42.28M	36M	54M	102M	146M
Other Non Current Liabilities	315M	294M	362M	311M	401M
Total Liabilities	3.8B	3.94B	5.42B	5.38B	6.42B
Common Stock, Total	1.37M	1M	1M	1M	1M
Additional Paid In Capital	-	-	-	-	177M
Retained Earnings	3.6B	3.68B	3.86B	3.77B	3.29B
Comprehensive Income and Other	-171M	-233M	-206M	-379M	-226M
Total Common Equity	3.43B	3.45B	3.66B	3.39B	3.24B
Minority Interest	1.25B	1.22B	1.5B	1.44B	1.55B
Total Equity	4.68B	4.67B	5.15B	4.84B	4.79B
Total Liabilities And Equity	8.48B	8.61B	10.57B	10.22B	11.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	137M	131M	129M	124M	115M
ECS Total Common Shares Outstanding	137M	132M	129M	124M	116M
Book Value / Share	24.97	26.15	28.28	27.33	28.03
Tangible Book Value	-162M	-113M	-1.23B	-1.61B	-2.1B
Tangible Book Value Per Share	-1.18	-0.86	-9.52	-12.94	-18.12
Total Debt	1.22B	1.5B	2.74B	2.87B	3.44B
Net Debt	1.1B	1.38B	2.57B	2.75B	3.28B
Debt Equivalent of Unfunded Proj. Benefit Obligation	53.14M	35M	39M	39M	40M
Debt Equivalent Oper. Leases	828M	1.2B	968M	1.04B	920M
Minority Interest, Total (Incl. Fin. Div)	1.25B	1.22B	1.5B	1.44B	1.55B
Equity Method Investments, Total	168M	161M	180M	170M	174M
Account Code - Inventory Valuation	5	5	5	6	6
Inventories - Raw Materials, Total	-	-	-	61M	70M
Inventories - Work In Process, Total	-	-	-	39M	43M
Inventories - Finished Goods, Total	-	-	-	1.71B	1.89B
Land - (BS)	21.12M	20M	21M	20M	22M
Buildings, Total	140M	135M	166M	164M	187M
Machinery, Total	658M	707M	880M	908M	1.05B
Full Time Employees	21.6K	22K	25K	25K	25K
Accumulated Allowance for Doubtful Accounts (Supple)	67.17M	65M	83M	78M	90M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	631M	538M	416M	390M	398M
Depreciation & Amortization - CF	85.73M	86M	96M	83M	101M
Amortization of Goodwill and Intangible Assets - (CF)	124M	126M	152M	185M	180M
Depreciation & Amortization, Total	210M	212M	248M	268M	281M
(Gain) Loss From Sale Of Asset	-	-	-	29M	30M
(Gain) Loss on Sale of Investments - (CF)	-9.76M	-	-	-	-
Asset Writedown & Restructuring Costs	713K	127M	61M	44M	24M
(Income) Loss On Equity Investments - (CF)	-2.25M	0	1M	-1M	-1M
Stock-Based Compensation (CF)	78.42M	54M	39M	39M	39M
Provision and Write-off of Bad Debts	-7.75M	5M	18M	14M	16M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	6.64M	-53M	7M	-75M	-27M
Change In Accounts Receivable	4.16M	-7M	-327M	315M	-124M
Change In Inventories	-295M	-126M	231M	-59M	-95M
Change In Accounts Payable	84.71M	-96M	-56M	-163M	216M
Change in Other Net Operating Assets	9.06M	-52M	-138M	47M	-45M
Cash from Operations	710M	602M	500M	848M	712M
Capital Expenditure	-79.02M	-96M	-147M	-148M	-139M
Cash Acquisitions	-579M	-158M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-40M	-39M	-52M
Investment in Marketable and Equity Securities, Total	18.02M	-	-955M	-230M	-199M
Other Investing Activities, Total	-37.4M	-22M	7M	-13M	-10M
Cash from Investing	-677M	-276M	-1.14B	-430M	-400M
Short Term Debt Issued, Total	-	48M	153M	387M	108M
Long-Term Debt Issued, Total	305M	270M	1.37B	120M	489M
Total Debt Issued	305M	318M	1.52B	507M	597M
Short Term Debt Repaid, Total	-18.41M	-	-	-	-
Long-Term Debt Repaid, Total	-122M	-59M	-468M	-318M	-44M
Total Debt Repaid	-141M	-59M	-468M	-318M	-44M
Issuance of Common Stock	-	2M	1M	6M	252M
Repurchase of Common Stock	-409M	-517M	-284M	-394M	-865M
Other Financing Activities, Total	-88.6M	-59M	-69M	-311M	-128M
Cash from Financing	-333M	-315M	701M	-510M	-188M
Foreign Exchange Rate Adjustments	-2.63M	-12M	-12M	43M	-90M
Net Change in Cash	-303M	-1M	54M	-49M	34M
Supplemental Items
Cash Interest Paid	29.46M	47M	84M	132M	151M
Cash Income Tax Paid (Refund)	242M	265M	218M	144M	128M
Levered Free Cash Flow	500M	419M	181M	804M	383M
Unlevered Free Cash Flow	517M	447M	235M	885M	477M
Change In Net Working Capital	222M	272M	299M	-296M	116M
Net Debt Issued / Repaid	164M	259M	1.05B	189M	553M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.52	6.42	4.53	4.52	4.33
Return on Total Capital	9.46	9.1	6.18	6.01	5.82
Return On Equity %	14.7	12.11	8.88	7.97	8.7
Return on Common Equity	18.64	15.66	11.72	11.07	11.99
Margin Analysis
Gross Profit Margin %	29.61	30.29	31.29	31.69	31.14
SG&A Margin	22.77	21.91	23.96	23.78	23.51
EBITDA Margin %	8.53	8.62	7.64	8.04	7.76
EBITA Margin %	7.84	7.94	6.86	7.39	6.99
EBIT Margin %	6.84	6.94	5.63	5.93	5.63
Income From Continuing Operations Margin %	5.33	4.48	3.53	3.14	3.18
Net Income Margin %	5.09	4.25	3.37	3.08	3.02
Net Avail. For Common Margin %	5.09	4.25	3.37	3.08	3.02
Normalized Net Income Margin	4.09	4.06	3.06	3.17	2.85
Levered Free Cash Flow Margin	4.03	3.32	1.47	6.34	2.9
Unlevered Free Cash Flow Margin	4.17	3.53	1.91	6.99	3.62
Asset Turnover
Asset Turnover	1.53	1.48	1.29	1.22	1.23
Fixed Assets Turnover	18.76	18.63	16.56	15.39	15.1
Receivables Turnover (Average Receivables)	8.62	8.74	7.47	7.58	8.42
Inventory Turnover (Average Inventory)	5.17	4.61	4.49	4.78	4.76
Short Term Liquidity
Current Ratio	1.67	1.79	1.67	1.42	1.38
Quick Ratio	0.68	0.7	0.76	0.57	0.56
Operating Cash Flow to Current Liabilities	0.31	0.27	0.19	0.3	0.22
Days Sales Outstanding (Average Receivables)	42.22	42.45	48.75	48.04	43.25
Days Outstanding Inventory (Average Inventory)	70.34	80.46	81.1	76.21	76.42
Average Days Payable Outstanding	41.29	42.81	44.22	41.69	41.54
Cash Conversion Cycle (Average Days)	71.27	80.1	85.63	82.56	78.13
Long Term Solvency
Total Debt/Equity	26.02	32.05	53.19	59.4	71.74
Total Debt / Total Capital	20.65	24.27	34.72	37.26	41.77
LT Debt/Equity	23.08	28.15	43.61	43.19	53.42
Long-Term Debt / Total Capital	18.31	21.32	28.46	27.09	31.11
Total Liabilities / Total Assets	44.86	45.73	51.26	52.66	57.25
EBIT / Interest Expense	30.73	19.95	7.99	5.73	4.95
EBITDA / Interest Expense	42.07	28.18	12.23	8.77	7.59
(EBITDA - Capex) / Interest Expense	39.21	26	10.54	7.64	6.66
Total Debt / EBITDA	1.05	1.21	2.58	2.5	3.02
Net Debt / EBITDA	0.95	1.11	2.42	2.39	2.88
Total Debt / (EBITDA - Capex)	1.12	1.31	2.99	2.87	3.44
Net Debt / (EBITDA - Capex)	1.02	1.21	2.8	2.75	3.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	22.55	1.98	-2.44	2.71	4.03
Gross Profit, 1 Yr. Growth %	30.49	4.27	0.78	4.04	2.22
EBITDA, 1 Yr. Growth %	40.65	1.87	-13.49	7.26	0.39
EBITA, 1 Yr. Growth %	44.56	2.03	-15.64	6.36	-1.5
EBIT, 1 Yr. Growth %	49.74	2.09	-20.84	3.16	-1.2
Earnings From Cont. Operations, 1 Yr. Growth %	57.86	-14.24	-22.97	-8.72	5.28
Net Income, 1 Yr. Growth %	56.33	-14.74	-22.68	-6.25	2.05
Normalized Net Income, 1 Yr. Growth %	50.54	1.18	-26.54	0.97	-6.65
Diluted EPS Before Extra, 1 Yr. Growth %	58.36	-12.13	-19.18	-3.48	7.21
Accounts Receivable, 1 Yr. Growth %	1.9	-0.69	29.2	-20.45	11.4
Inventory, 1 Yr. Growth %	23.05	5.48	-7.54	-0.28	10.61
Net Property, Plant and Equip., 1 Yr. Growth %	9.6	-3.47	23.39	0.12	11.89
Total Assets, 1 Yr. Growth %	9.12	1.49	22.84	-3.36	9.76
Tangible Book Value, 1 Yr. Growth %	-151.15	-30.25	989.38	30.54	30.55
Common Equity, 1 Yr. Growth %	2.3	0.61	6.06	-7.17	-4.36
Cash From Operations, 1 Yr. Growth %	18.48	-15.21	-16.94	69.6	-16.04
Capital Expenditures, 1 Yr. Growth %	61.82	21.52	53.12	0.68	-6.08
Levered Free Cash Flow, 1 Yr. Growth %	19.03	-17.32	-53.93	385.13	-52.33
Unlevered Free Cash Flow, 1 Yr. Growth %	15.99	-14.83	-43.25	302.44	-46.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.44	11.8	-0.25	0.1	3.37
Gross Profit, 2 Yr. CAGR %	9	16.64	2.51	2.39	3.12
EBITDA, 2 Yr. CAGR %	7.35	20.31	-6.12	-2.91	3.77
EBITA, 2 Yr. CAGR %	7.49	22.14	-7.22	-3.88	2.36
EBIT, 2 Yr. CAGR %	7.57	24.44	-10.1	-7.99	0.96
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.58	16.23	-18.72	-16.14	-1.97
Net Income, 2 Yr. CAGR %	-4.68	15.4	-18.8	-14.86	-2.19
Normalized Net Income, 2 Yr. CAGR %	9.84	25.94	-13.79	-12.03	-2.92
Diluted EPS Before Extra, 2 Yr. CAGR %	-2.59	17.96	-15.73	-11.68	1.73
Accounts Receivable, 2 Yr. CAGR %	7.93	0.6	13.27	1.38	-5.86
Inventory, 2 Yr. CAGR %	14.13	13.92	-1.24	-3.98	5.03
Net Property, Plant and Equip., 2 Yr. CAGR %	10.99	2.83	9.13	11.15	5.84
Total Assets, 2 Yr. CAGR %	8.9	5.23	11.65	8.96	2.99
Tangible Book Value, 2 Yr. CAGR %	42.5	-40.27	175.66	277.11	30.55
Common Equity, 2 Yr. CAGR %	6.89	1.45	3.3	-0.77	-5.78
Cash From Operations, 2 Yr. CAGR %	4.16	0.25	-16.08	18.69	19.33
Capital Expenditures, 2 Yr. CAGR %	1.82	39.97	36.41	24.16	-2.76
Levered Free Cash Flow, 2 Yr. CAGR %	-34.31	-0.2	-38.25	45.32	52.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	-34.08	0.02	-30.8	48.34	47.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.61	8.19	6.84	0.73	1.4
Gross Profit, 3 Yr. CAGR %	8.05	7.42	11.09	3.01	2.33
EBITDA, 3 Yr. CAGR %	8.11	5.9	7.79	-1.61	-1.82
EBITA, 3 Yr. CAGR %	8.13	6.07	7.97	-1.65	-3.09
EBIT, 3 Yr. CAGR %	6.94	6.2	7.02	-4.42	-5.78
Earnings From Cont. Operations, 3 Yr. CAGR %	13.61	-7.94	1.33	-15.52	-9.54
Net Income, 3 Yr. CAGR %	5.61	-8.17	0.98	-14.82	-9.56
Normalized Net Income, 3 Yr. CAGR %	9.47	6.89	5.23	-7.5	-10.28
Diluted EPS Before Extra, 3 Yr. CAGR %	16.7	-5.88	3.99	-11.83	-5.78
Accounts Receivable, 3 Yr. CAGR %	7.5	4.98	9.35	0.68	4.62
Inventory, 3 Yr. CAGR %	9.55	11.17	6.27	-0.92	0.66
Net Property, Plant and Equip., 3 Yr. CAGR %	30.07	5.92	9.27	6.04	11.4
Total Assets, 3 Yr. CAGR %	-0.08	6.37	10.8	6.41	9.22
Tangible Book Value, 3 Yr. CAGR %	-29.69	12.31	57.23	114.87	164.79
Common Equity, 3 Yr. CAGR %	4.97	4.75	2.97	-0.31	-1.98
Cash From Operations, 3 Yr. CAGR %	1.2	-2.73	-5.84	6.1	5.75
Capital Expenditures, 3 Yr. CAGR %	3.49	7.99	44.22	23.28	13.13
Levered Free Cash Flow, 3 Yr. CAGR %	1.9	-28.73	-24.52	19.18	0.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0.18	-27.86	-19.22	21.67	5.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.39	7.32	5.55	4.88	5.43
Gross Profit, 5 Yr. CAGR %	2.62	6.88	5.81	5.38	7.83
EBITDA, 5 Yr. CAGR %	1.39	6.15	2.41	2.11	6.32
EBITA, 5 Yr. CAGR %	1.2	6.14	1.96	2.16	6.5
EBIT, 5 Yr. CAGR %	0.74	5.4	0.04	0.49	5.53
Earnings From Cont. Operations, 5 Yr. CAGR %	3.49	12.19	-0.65	-11.31	0
Net Income, 5 Yr. CAGR %	4.49	5.78	-4.94	-10.91	-0.3
Normalized Net Income, 5 Yr. CAGR %	1.86	6.15	-0.49	-0.91	2.98
Diluted EPS Before Extra, 5 Yr. CAGR %	7.5	16.15	2.45	-8.25	3.08
Accounts Receivable, 5 Yr. CAGR %	2.97	-1.08	9.77	3.53	2.99
Inventory, 5 Yr. CAGR %	2.24	0.3	5.1	4.84	5.77
Net Property, Plant and Equip., 5 Yr. CAGR %	15.67	12.21	21.24	7.98	7.88
Total Assets, 5 Yr. CAGR %	4.64	1.82	4.46	7.4	7.61
Tangible Book Value, 5 Yr. CAGR %	6.56	-10.45	21.44	82.32	45.96
Common Equity, 5 Yr. CAGR %	4.16	4.15	4.3	2.51	-0.62
Cash From Operations, 5 Yr. CAGR %	2	1.99	-6.09	5.33	3.52
Capital Expenditures, 5 Yr. CAGR %	2.4	9	15.58	14.19	23.19
Levered Free Cash Flow, 5 Yr. CAGR %	-1.67	28.27	-17.46	-7.05	-1.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.71	23.95	-14.66	-5.74	1.32